Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 20, 2020
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
Leland Gershell Initiated (ASND) at Buy and Held Target at $199 on, Mar 20th, 2020
Leland Gershell of Oppenheimer, Initiated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $199 on, Mar 20th, 2020.
Leland has made no other calls on ASND in the last 4 months.
There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Leland's Rating of Hold.
This is the rating of the analyst that currently disagrees with Leland
- David Lebovitz of "Morgan Stanley" Maintained at Buy with Increased Target to $181 on, Wednesday, February 26th, 2020
Similar Stocks and Investing Articles
[ Tue, Mar 03rd 2020
] - WOPRAI
[ Fri, Oct 11th 2019
] - WOPRAI
[ Tue, Jun 26th 2018
] - WOPRAI
[ Thu, Mar 01st 2018
] - WOPRAI
[ Thu, Aug 10th 2017
] - WOPRAI
[ Thu, Mar 09th 2017
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Wed, Apr 25th 2012
] - WOPRAI
[ Tue, Mar 27th 2012
] - WOPRAI
[ Tue, Mar 06th 2012
] - WOPRAI